VEGFA and cancer: Although approaches targeting the VEGF pathway are a common and effective strategy to treat various types of cancer, VEGF inhibitors have many disadvantages, including a transient effect, resistance mechanisms and organ toxicity [120–123], partially because VEGF is also a key regulator of angiogenesis in physiological processes.